EyePod

John Kitchens, MD, sits down with David Brown, MD, to discuss the PULSAR results and their relation to patients with neovascular age-related macular degeneration in clinical practice.  

John Kitchens, MD, sits down with Diana Do, MD, to discuss the PHOTON results and their relation to patients with diabetic macular edema in clinical practice.

John Kitchens, MD, is joined by Peter Kaiser, MD, to discuss higher molar dose and its translation into clinical practice

This PER On Air - Ophthalmology Times podcast examines the new treatment paradigm for patients with geographic atropy, following the introduction of complement-targeting therapies. In this podcast, experts, Dr Cecelia Koetting and Dr Talia Kaden review some of the key highlights from the live satellite symposium, Community Practice Connection™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention presented at the 2024 EnVision Summit in Ophthalmology.

In this PER On Air Ophthalmology Times podcast, a team of experts provides insights into the diagnosis and management of patients with NK (including assessing their underlying cause of NK), with a look at the range of treatments available for patients with advanced stages of NK.

In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment.

Faculty:

Roger A. Goldberg, MD, MBA

Vitreoretinal Specialist

Bay Area Retina Associates

Volunteer Faculty

California Pacific Medical Center

Walnut Creek, CA

David R.P. Almeida, MD, PhD, MBA

President and CEO

Erie Retina Research

Center for Advanced Surgical Exploration

Erie, PA

Jennifer I. Lim, MD, FARVO

Marion H. Schenk Esq. Chair in Ophthalmology for Research of the Aging Eye

UIC Distinguished Professor of Ophthalmology

Director, Retina Service

Vice-Chair, Diversity and Inclusion

University of Illinois at Chicago

Chicago, IL

In this Ophthalmology Times EyePod podcast, Mandeep S. Singh, MD, PhD, speaks with Mark S. Humayun, MD, PhD, to learn about the progress in developing a stem cell patch for treating advanced dry age-related macular degeneration.

Developed by a team of researchers at USC, the stem cell patch represents a significant advancement in treatment. Dr. Humayun talks about the inspiration behind the patch, how his expertise in both ophthalmology and biomedical engineering has been crucial, and insights gained from a Phase 1/2a study.

Dr. Humayun also outlines the upcoming steps for a multisite Phase 2b clinical trial and envisions the potential future role of the stem cell patch in the treatment of geographic atrophy.

This podcast features engaging commentary from experts in the clinical management of glaucoma. These experts share information about traditional and newer therapies for glaucoma, including topical drops, sustained drug delivery options, and minimally invasive glaucoma surgery. They discuss safety and efficacy data with an emphasis on appropriate patient selection, as well as key take-home points and practice pearls.

Chair:

Inas Aboobakar, MD

Physician and Surgeon

Massachusetts Eye and Ear

Instructor in Ophthalmology

Harvard Medical School

Boston, MA

Faculty:

Janelle Davison, OD

Owner and CEO

Brilliant Eyes Vision Center

Owner and Clinical Director

Premier Dry Eye Spa & Cosmetic Eyecare

Marietta, GA

Eydie G. Miller-Ellis, MD

Professor of Clinical Ophthalmology

Perelman School of Medicine at the University of Pennsylvania

Director, Glaucoma Service

Vice Chair for Faculty Affairs

Scheie Eye Institute Perelman

Philadelphia, PA

The role of calendars may be growing more important when managing patients with nAMD and DME. How many weeks can patients go between injections with newer anti-VEGF agents versus older options? How short of an injection interval can patients tolerate before it becomes too much of a burden?

In this podcast, Murtaza Adam, MD; Laxmi Devisetty, MD, Hong-Uyen Hua, MD; and Sherrol Reynolds, OD; share insights into determining appropriate treatment regimens with these therapies and supporting patient adherence.

Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis